CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 150 enrolled
Drug / intervention
Stent Placement Timing - Early +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05089864
NCT05089864N/ACompleted
CompareCT.gov

Outcomes and Safety in Patients Treated With STAR and Deferred Stenting After Unsuccessful CTO PCI

Saint Luke's Health System·interventional·Posted Oct 22, 2021·Updated Oct 24, 2025

In Brief

A clinical study evaluating Stent Placement Timing - Early and Stent Placement Timing - Late for Coronary Occlusion and 2 related conditions. Completed, enrolled 150 participants across 1 site.

Detailed Summary

STAR is a minimal-risk pragmatic clinical trial of patients admitted for a CTO-PCI procedure. The overall objective of the STAR Study is to address the current gaps in knowledge regarding use of STAR during CTO-PCI, as a prospective, multi-center study of 150 participants with randomization of timing of staged PCI. Five sites will be selected to participate in STAR from a national network of highly experienced CTO-PCI centers across the United States.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Occlusion, Coronary Stenosis, Coronary Restenosis
CountriesUnited States
CollaboratorsAsahi-Intecc

Timeline

N/ACompletedFinished
20222023202420252026
First PostedOct 22, 2021
Enrollment StartNov 23, 2021
Primary CompletionAug 7, 2025
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 4.7 years ago

Interventions

Stent Placement Timing - Earlyother

Stent placement 5-7 weeks after STAR procedure

Stent Placement Timing - Lateother

Stent placement 12-14 weeks after STAR procedure